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creativecommons.org/licenses/by-nc-nd/4.0/).Abstract Background and aims: Studies regarding dietary patterns and cardiometabolic risk
markers during pregnancy are scarce. The aim of the present study was to analyse whether
different degrees of adherence to the Mediterranean diet (MD) and the MD components were
associated with cardiometabolic markers and a clustered cardiometabolic risk during pregnancy.
Methods and results: This study comprised 119 pregnant women from the GEStation and FITness
(GESTAFIT) project. Dietary habits were assessed with a food frequency questionnaire at the 16th
and 34th gestational weeks (g.w.). The Mediterranean Diet Score was employed to assess MD
adherence. The following cardiometabolic markers were assessed: pre-pregnancy body mass in-
dex (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting glucose, triglyc-
erides and high-density lipoprotein cholesterol (HDL-C). A greater MD adherence was associated
with a better cardiometabolic status in cross-sectional (16th g.w. and 34th g.w.) and prospective
analyses (MD adherence at the 16th g.w. and cardiometabolic markers at the 34th g.w.; SBP, DBP
and HDL-C; all, p < 0.05). Participants with the highest MD adherence (Tertile 3) had a lower
clustered cardiometabolic risk than those with the lowest MD adherence (Tertile 1) at the
16th and 34th g.w. (both, p < 0.05). A higher intake of fruits, vegetables and fish and a lower
intake of refined cereals and red meat and subproducts were associated with a lower cardiome-
tabolic risk during pregnancy (all, p < 0.05).
Conclusion: A higher MD adherence, a greater intake of fruits, vegetables and fish and a lower
intake of refined cereals and red meat and subproducts showed a cardioprotective effect
throughout gestation.
ª 2021 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Ital-
ian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the
Department of Clinical Medicine and Surgery, Federico II University. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).x; CVD, cardiovascular disease; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein-
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During pregnancy, essential cardiometabolic changes
occur in order to allow foetal growth [1]. Nevertheless, an
inadequate adaptation to these changes (i.e. adverse car-
diometabolic markers, including high level of triglycerides,
glucose, high blood pressure, maternal obesity and low
levels of high-density lipoprotein cholesterol [HDL-C]),
may result in an increased risk of cardiometabolic dis-
eases, such as gestational hypertension, preeclampsia and
gestational diabetes mellitus [1e3].
Dietary patterns during gestation are potential modifi-
able behaviours that may exert a positive influence on
pregnancy cardiometabolic markers [1]. In this regard, the
Mediterranean diet (MD) has been associated with a better
cardiometabolic status and a lower cardiometabolic risk in
adult population [4e9]. Notwithstanding, studies regarding
dietary patterns and cardiometabolic risk markers during
pregnancy are scarce [1,10]. For instance, a Mediterranean-
style diet in pregnancy has been associated with a lower
risk of gestational diabetes [10]; a dietary pattern charac-
terized by a high intake of fruits, vegetables, whole grains,
low fat dairy, breakfast bars and water has been associated
with lower maternal glucose levels and insulin resistance
[1]; the Dietary Approaches to Stop Hypertension score-
based method has been associated with lower levels of
maternal triglycerides [1], better glucose tolerance, blood
pressure and overall lipid profile [11]; and a dietary pattern
comprising a high intake of vegetables, vegetable oils,
pasta, rice, fish and legumes, a moderate intake of alcohol
and a low intake of sweets has been associated with lower
maternal blood pressure [12]. Importantly, pregnant
women with a worse metabolic profile are more likely to
have adverse maternal (preterm delivery, preeclampsia or
gestational diabetes mellitus) and foetal (small/large for
gestational age, neonatal asphyxia or foetal demise) out-
comes [2]. Therefore, the main aim of the present study
was to explore whether different degrees of adherence to
the MD were associated with cardiometabolic markers and
a clustered cardiometabolic risk in pregnant women. A
secondary, exploratory aim was to study the association
of specific MD components with this clustered car-
diometabolic risk.
Methods
Study design and participants
The present longitudinal study is part of the GEStation and
FITness (GESTAFIT) project, where a novel exercise inter-
vention was conducted [13]. The complete methodology of
this project (including the eligibility criteria and the
sample size calculation) has been published elsewhere
[13]. The sample size was only determined for the primary
outcome of the GESTAFIT project (maternal weight gains
and maternal/neonatal glycaemic profile) resulting in 52
pregnant women (26 per group) [13]. This study was
approved by the Ethics Committee on Clinical Research of
Granada, Regional Government of Andalusia, Spain (code:GESFIT-0448-N-15). Of the 384 pregnant women assessed
for eligibility, 159 were recruited (Supplementary Fig. S1)
and signed a written informed consent.
The evaluation procedures were performed on 2 non-
consecutive days. At the 16th gestational week (g.w.), data
on nutritional and clinical information (e.g. smoking habit
and alcohol intake) were gathered through face-to-face
interviews by trained staff. In addition, blood pressure
and body composition were assessed (in the same order
as mentioned). On the second appointment, participants
attended our research centre for blood sample extractions.
At the 34th g.w., a second assessment was carried out
where trained staff gathered the same information as they
previously did.Exercise intervention
The exercise program carried out in the GESTAFIT project
was designed following the standards of the American
College of Obstetricians and Gynecologists [14] and has
been previously detailed [15,16]. Briefly, women random-
ized into the exercise group followed a concurrent exercise
program (60 min/session, 3 days/week of combined aero-
bic and strength training) from the 17th g.w. until delivery.Control group
Pregnant women allocated to the control group did not
participate in the training sessions and were asked to
continue with their usual activities. For ethical reasons, the
research team held a series of conferences to address the
importance of physical activity and healthy dietary habits
during pregnancy (Appendix A).
Both the control and exercise groups attended these
conferences.Maternal anthropometry and body composition
At the first evaluation, height was measured using a sta-
diometer (Seca 22, Hamburg, Germany). Pre-pregnancy
body weight (kg) was self-reported. These values were
used to calculate the pre-pregnancy body mass index
(BMI), as weight (kg) divided by squared height (m2). The
pre-pregnancy weight status classified based on the self-
reported pre-pregnancy weight and height has been pre-
viously validated [17].Vascular function
A blood pressure monitor (M6 upper arm blood pressure
monitor Omron. Omron Health Care Europe B.V. Hoold-
dorp, The Netherlands) was used to assess systolic blood
pressure (SBP) and diastolic blood pressure (DBP), which
were measured after 5 min of rest on two separate occa-
sions (with 2 min between trials) with the person seated.
Both values were recorded, although only the lowest value
of the two trials was selected for the analysis.
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Venous blood samples (5 mL) after all night fasting were
collected in serum tubes. The blood sample was allowed to
clot (coagulation) at room temperature for 30 min. Then,
samples were centrifuged at 1750 rpm during 10 min at
4 C in a refrigerated centrifuge (GS-6R Beckman Coulter,
Brea, CA, USA) to obtain serum. Glucose, triglycerides and
HDL-C were assessed with standard procedures using an
auto-analyser (AU5822 Clinical Chemistry Analyzer, Beck-
man Coulter, Brea, CA, USA).
Clustered cardiometabolic risk
A clustered cardiometabolic risk (Z-score) was created as
the mean of the standardized scores [(value - mean)/
standard deviation] of pre-pregnancy BMI, mean blood
pressure [defined as (SBP þ DBP)/2], serum fasting glucose,
triglycerides and HDL-C, since these factors have been
previously employed as a cluster of metabolic risk factors
during pregnancy [2]. For variables characterized by a
lower metabolic risk with increasing values (HDL-C), z-
scores were multiplied by e 1. A higher clustered car-
diometabolic status indicates a higher cardiometabolic
risk.
Physical activity levels
Participants were asked to wear a tri-axial accelerometer
attached to their waist (Actigraph GT3Xþ, Pensacola,
Florida, US) for 9e consecutive days, 24 h/day [18]. The
total physical activity (min/day) was calculated.
Dietary assessment and mediterranean diet adherence
A validated food frequency questionnaire designed by
Mataix et al. [19] was administered to participants by a
trained nutritionist at the 16th and 34th g.w. asking about
their dietary habits.
Mediterranean diet adherence
The Mediterranean Diet Score was used to assess MD
adherence [20]. It was calculated by using dietary data
obtained from a food frequency questionnaire [19]. The
Mediterranean Diet Score consists of eleven variables
(whole-grain cereals, potatoes, fruits, vegetables, pulses,
fish, olive oil, red wine, red meat and subproducts, poultry
and whole dairy products) ranging from 0 to 5 according
to their position in the MD pyramid [21]. The total score
ranges from 0 to 55, with higher values indicating a
greater adherence to the MD, and therefore, higher diet
quality. A moderate alcohol intake, also typical of the MD,
was not considered for calculating the index in this group
of women, as they must not drink alcohol during this
period. Therefore, the maximum score considered for
these analyses in pregnant women was 50 points. Because
there are no available pre-specified cut-off points for
pregnant population, the Mediterranean Diet Score wasdivided into tertiles with participants being categorized as
having low, medium or high MD adherence (Tertile 1,
Tertile 2 and Tertile 3, respectively).
Statistical analysis
Descriptive statistics (mean  standard deviation for
quantitative variables and number of women [%] for cat-
egorical variables) were used to describe sociodemo-
graphic and clinical characteristics of the study
participants at baseline (16th g.w.). Nominal variables
were analysed by using the chi-squared test.
Linear regression analyses after adjusting for maternal
age, smoking habit (at the 16th and 34th g.w.) and the
exercise intervention (at the 34th g.w.) were used to
explore crossesectional associations of MD adherence
with cardiometabolic risk biomarkers and clustered car-
diometabolic risk at the 16th (n Z 119) and 34th g.w
(n Z 103). In addition, prospective analyses (n Z 107)
were performed to analyse the association of the MD
adherence at the 16th g.w. with cardiometabolic risk bio-
markers and the clustered cardiometabolic risk at the 34th
g.w. The statistical power analyses showed statistical
power of 95% to detect small-to-medium association sizes
at the 16th g.w. (n Z 119, minimum detectable f2 Z 0.11)
and at the 34th g.w. (n Z 103, minimum detectable
f2 Z 0.13) [22].
The Mediterranean Diet Score was divided into tertiles.
Subsequently, the clustered cardiometabolic risk was
compared across the tertiles by a one-way analysis of
covariance (ANCOVA) after adjusting for maternal age,
smoking habit (at the 16th and 34th g.w.) and the exer-
cise intervention (at the 34th g.w.) for both, cross-
sectional and prospective associations. Post-hoc multi-
ple comparisons (Bonferroni’s correction) were applied to
examine pairwise differences between groups (e.g. Tertile
1 vs. Tertile 3).
Linear regression analyses after adjusting for maternal
age, smoking habit (at the 16th and 34th g.w.) and the
exercise intervention (at the 34th g.w.) were used to
explore cross-sectional and prospective associations of the
MD adherence with the clustered cardiometabolic risk at
the 16th and 34th g.w.
A paired Student’s t-test was performed to explore
differences in total physical activity levels, body weight,
MD components and MD adherence of pregnant women
by g.w. (16th versus 34th g.w.).
The BenjaminieHochberg procedure [23] was applied
to account for the random effect in multiple comparisons
for all the tests included in the primary analysis (i.e. MD
adherence associations with cardiometabolic risk bio-
markers and clustered cardiometabolic risk), and sepa-
rately for all the tests included in the dietary habits
analysis (i.e. dietary habits associations with clustered
cardiometabolic risk) with q Z 0.05.
All analyses were conducted using the Statistical Pack-
age for Social Sciences (IBM SPSS Statistics for Windows,
version 22.0, Armonk, NY) and the level of significance was
set at p  0.05.
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The total sample size for the present analyses comprised
119 Caucasian pregnant women (33.2  4.4 years, pre-
pregnancy BMI 24.1  4.1 kg/m2) who had valid data in the
food frequency questionnaire [19], vascular function,
biochemical markers and body composition measure-
ments (Supplementary Fig. S1). The descriptive charac-
teristics of the study sample according to the tertiles of MD
adherence are shown in Table 1.
Differences in total physical activity, body weight, di-
etary habits and MD adherence of pregnant women by
g.w. (16th versus 34th g.w.) are shown in Supplementary
Table S1. At the 34th g.w. pregnant women had lower
levels of total physical activity (pZ0.001), higher body
weight (pZ0.001), a higher intake of fruits (pZ0.007)
and vegetables with evidence of statistical significance
(pZ0.057) compared to the 16th g.w.
The association of MD adherence, cardiometabolic risk
biomarkers and clustered cardiometabolic risk are shown
in Table 2. The cross-sectional analyses showed that a
greater adherence to the MD at the 16th g.w. was associ-
ated with lower pre-pregnancy BMI, SBP, greater HDL-C
and a lower clustered cardiometabolic risk (all, p < 0.05).
At the 34th g.w. a higher MD adherence was associated
with lower SBP, DBP, higher HDL-C and a lower clustered
cardiometabolic risk (all, p < 0.05). Regarding the pro-
spective analyses, a greater MD adherence at the 16th g.w.
was associated with lower pre-pregnancy BMI, SBP, DBP,
triglycerides, higher HDL-C and a lower clustered car-
diometabolic risk at the 34th g.w. (all, p < 0.05). WeTable 1 Descriptive characteristics of the study participants at baseline (
Variable Total cohort (n Z 119) Tert
Age (years) 33.2 (4.4) 32.9
Pre-pregnancy weight (kg) 65.1 (12.2) 66.9
Pre-pregnancy BMI (kg/m2) 24.1 (4.1) 24.8
Underweight 3 (2.5) 1 (2
Normal weight 74 (62.2) 22 (
Overweight 30 (25.2) 11 (
Obese 12 (10.1) 6 (1
Mediterranean diet adherence (0e50) 29.0 (4.0) 24.7
Vascular function
Systolic blood pressure (mmHg) 107.8 (9.3) 109
Diastolic blood pressure (mmHg) 64.3 (7.9) 65.2
Glycaemic and lipid profile
Fasting glucose (mg/dL) 77.4 (15.9) 77.0
HDL-cholesterol (mg/dL) 68.2 (11.4) 63.2
Triglycerides (mg/dL) 121.3 (48.9) 130
Educational Status n (%)
Low educational status 13 (10.9) 6 (1
Medium educational status 36 (30.3) 13 (
High educational status 70 (58.8) 21 (
Smoking habit
Current smoker 10 (8.4) 5 (1
Former smoker 44 (37.0) 9 (2
Never smoker 65 (54.6) 26 (
Alcohol consumption (no) 119 (100) e
Taking nutritional supplements (yes) 102 (85.7) 31 (
SD, Standard deviation. BMI, body mass index; HDL, high-density lipoproperformed an additional analysis adjusting for objectively
measured total physical activity (min/day) and educational
status but results remained the same (data not shown).
After correcting for multiplicity, we observed that the
crossesectional associations between MD adherence (at
the 16th g.w.) and BMI and the prospective associations
between MD adherence (at the 16th g.w.) and BMI, DBP
and triglycerides (at the 34th g.w.) became non-significant.
The clustered cardiometabolic risk profile (Z-score) by
the tertiles of the Mediterranean Diet Score is shown in
Fig. 1. In the cross-sectional analyses, the group with the
highest MD adherence (Tertile 3) had a lower car-
diometabolic risk than the group with the lowest MD
adherence (Tertile 1) at both, the 16th and 34th g.w. (P-
trend Z 0.028 and P-trend Z 0.002, respectively). In
addition, the prospective analyses showed that partici-
pants with the highest adherence to the MD (Tertile 3) had
a lower cardiometabolic risk than those participants with
low (Tertile 1) and medium (Tertile 2) MD adherence (P-
trend<0.001).
The associations of MD components with the clustered
cardiometabolic risk (Z-score) at the 16th and the 34th
g.w. are shown in Table 3. In the cross-sectional analyses,
a higher intake of fruits and fish and a lower intake of
red meat and subproducts were associated with a lower
clustered cardiometabolic risk at the 16th g.w. (all,
p < 0.05). At the 34th g.w., a greater intake of fruits was
associated with a lower clustered cardiometabolic risk and
a higher intake of red meat and subproducts and white
bread and rice were associated with a higher clustered
cardiometabolic risk (all, p < 0.05). The prospectiven Z 119).
ile 1 (n Z 40) Tertile 2 (n Z 45) Tertile 3 (n Z 34) p
(4.1) 34.1 (4.4) 32.6 (4.8) 0.269
(13.4) 64.1 (10.7) 64.3 (12.6) 0.520
(4.7) 24.2 (3.9) 23.2 (3.7) 0.240
.5) 1 (2.2) 1 (2.9) 0.888
55.0) 29 (64.4) 23 (67.6)
27.5) 11 (24.4) 8 (23.5)
5.0) 4 (8.9) 2 (5.9)
(2.1) 29.6 (1.1) 33.5 (1.6) <0.001
.0 (9.9) 108.2 (8.8) 105.9 (9.2) 0.336
(8.9) 64.9 (7.7) 62.3 (6.8) 0.226
(6.7) 78.3 (15.4) 76.7 (23.1) 0.897
(9.9) 70.9 (11.3) 70.4 (11.7) 0.003
.2 (50.4) 117.7 (49.8) 115.5 (45.5) 0.362
5.0) 2 (4.4) 5 (14.7) 0.125
32.5) 10 (22.2) 13 (38.2)
52.5) 33 (73.3) 16 (47.1)
2.5) 3 (6.7) 2 (5.9) 0.088
2.5) 23 (51.1) 12 (35.3)
65.0) 19 (42.2) 20 (58.8)
e e
77.5) 39 (86.7) 32 (94.1) 0.123
tein.
Table 2 Association of Mediterranean diet adherence, cardiometabolic risk biomarkers and clustered cardiometabolic risk during pregnancy.















Pre-pregnancy BMI 0.196 0.034 0.139 0.161 0.199 0.041
SBP 0.225 0.015 0.284 0.003 0.260 0.007
DBP 0.166 0.073 0.240 0.015 0.198 0.044
Glucose 0.022 0.813 0.145 0.139 0.171 0.079
Triglycerides 0.149 0.109 0.073 0.465 0.194 0.047




0.309 0.001 0.332 0.001 0.428 <0.001
a Model adjusted for maternal age and smoking habit.
b Model additionally adjusted for exercise intervention. Bold values indicate those outcomes which surpassed the multiple comparison test.
BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure. *A higher clus-
tered cardiometabolic status entails higher cardiometabolic risk.
Mediterranean diet and cardiometabolic status. 2315analyses showed that a greater intake of fruits, vegetables,
fish and pulses at the 16th g.w. was associated with a
lower cardiometabolic risk at the 34th g.w. (all, p < 0.05).
Of note, after correcting for multiplicity, we could observe
that the associations between fruits and the clustered
cardiometabolic risk throughout gestation remained sig-
nificant. In addition, the crossesectional association be-
tween red meat and subproducts and cardiometabolic risk
(at the 34th g.w.) remained significant.Discussion
Our results suggest that the MD adherence was associ-
ated with most of the studied cardiometabolic markers
throughout pregnancy. Moreover, a clear cardioprotective
effect was observed across gestation only when the high-
est MD adherence was reached (Tertile 3) regardless of
potential confounders such as age, smoking habit and
exercise. In addition, a higher intake of fruits, vegetables
and fish and a lower intake of refined cereals and red
meat and subproducts were associated with a lower car-
diometabolic risk during gestation. Of note, individual as-
sociations between food groups and cardiometabolic risk
were less significant than the association between the MD
adherence and the cardiometabolic risk.
The lifestyle habits, sociodemographic and clinical
characteristics of the study sample were similar to those
observed in previous epidemiological studies conducted in
Spanish [24e26] and non-Spanish [1] pregnant pop-
ulations in the same age range. Regarding pre-pregnancy
body composition of the study sample (pre-pregnancy
BMI (23.2 kg/m2)), it was similar to that observed by
Martin et al. [1] in which pregnant women with the
highest adherence (Tertile 3) to the Dietary Approaches
to Stop Hypertension score-based method had a pre-
pregnancy BMI of 22.8 kg/m2 [1]. In addition, a recent
study [24] conducted in Spain reported that 37% ofpregnant women were overweight/obese prior to preg-
nancy, similar to our results (35%). Comparing the early
second trimester (16th g.w.) with the third trimester (34th
g.w.) we observed a higher intake of fruits and vegetables
as previously reported [26]. However, no differences were
found regarding MD adherence, suggesting that food
behaviours remained unchanged during pregnancy in
accordance with previous evidence [26]. Additionally, we
found that women had lower total physical activity levels
at the third trimester of pregnancy than that at the early
second trimester of pregnancy. This is in line with previ-
ous evidence that suggested that physical activity levels
decrease along gestation [27]. In particular, it has been
shown [24] that between the second and the third
trimester of pregnancy, there was a decrease in physical
activity (assessed with the International Physical Activity
Questionnaire), which is highly in agreement with our
findings. In this regard, the high prevalence of overweight
and obesity prior to pregnancy and the decreasing time
spent in total physical activity might imply a higher car-
diometabolic risk in this population [1,28,29].
In this context, previous studies [1,3,11,12] have sug-
gested that specific maternal dietary patterns (comprising
a high intake of vegetables, fruits, whole grains, fish and
nuts and a low consumption of meat, saturated fats and
refined grains) are associated with better results in car-
diometabolic markers, including triglycerides, glucose,
blood pressure and cholesterol. Similarly, we found that
the MD adherence was associated with a lower blood
pressure and higher HDL-C at the 16th and 34th g.w.
Compelling evidence [30,31] indicates that some dietary
strategies were effective for preventing cardiovascular
diseases (CVD) in a non-pregnant population, including an
increasing intake of omega-3 fatty acids from fish and a
high consumption of fruits, vegetables, nuts and whole-
grain cereals and with a low intake of refined cereals. A
Mediterranean dietary pattern has long been associated
with a lower incidence of CVD in the general population
Figure 1 Clustered cardiometabolic risk (z-score) by tertiles of Mediterranean Diet Score. Model adjusted for age and smoking habit at the 16th
gestational week. The model was additionally adjusted for exercise intervention at the 34th gestational week. Dots represent mean and bars
represent standard error. abSuperscript indicates a significant difference (p < 0.05) between groups with the same letter. Pairwise comparisons were
performed with Bonferroni’s adjustment (A) Clustered cardiometabolic risk by tertiles of Mediterranean Diet Score at the 16th gestational week (B)
Clustered cardiometabolic risk by tertiles of Mediterranean Diet Score at the 34th gestational week. A higher clustered cardiometabolic status entails
higher cardiometabolic risk.
2316 M. Flor-Alemany et al.[6]. Notwithstanding, a recent systematic review and meta-
analysis [32] concluded that there is still some uncertainty
regarding the effects of a Mediterranean-style diet on CVD
and cardiometabolic risk factors for both primary and
secondary CVD prevention. Therefore, it is clinically rele-
vant to determine the appropriate degree of adherence in
which the aforementioned cardiovascular protection could
be reached in pregnant women. This is especially impor-
tant as recent studies suggest that pregnant women are
drifting away from the MD-like pattern [26,33].
It has been recently proposed that women with several
cardiometabolic risk factors during pregnancy have a
higher risk of adverse pregnancy outcomes [2]. When we
further explored the association between MD and the
clustered cardiometabolic risk (Z-score) we found that aTable 3 Association of Mediterranean diet components with the clustere




Whole-grain cereals (s/week) 0.152 0.106
White bread and rice (s/week) 0.136 0.153
Potatoes (s/week) 0.004 0.963
Fruits (s/week) 0.255 0.006
Vegetables (s/week) 0.022 0.814
Pulses (s/week) 0.054 0.563
Fish (s/week) 0.209 0.032
Red meat and subproducts (s/week) 0.208 0.025
Poultry (s/week) 0.159 0.088
Dairy products (s/week) 0.014 0.884
Olive oil (s/week) 0.027 0.785
a Model adjusted for maternal age and smoking habit.
b Model additionally adjusted for exercise intervention. Bold values ind
BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density l
cardiometabolic status entails higher cardiometabolic risk.higher MD adherence was associated with a better clus-
tered cardiometabolic status throughout the pregnancy
course. This could be explained because this traditional
dietary pattern (typical among Mediterranean regions,
including Spain) has been suggested as an ideal model
for CVD prevention [34,35]. Interestingly, a clear car-
dioprotective effect throughout pregnancy was only
observed when the highest MD adherence was reached
(Tertile 3) regardless of potential confounders such as
age, smoking habit or exercise. This is in agreement with
previous evidence in non-pregnant adult population
[36,37], suggesting that a higher adherence to the MD
promoted cardioprotective effects.
A recent systematic review [38], where five MD









week (n Z 107)
b pb b pb
0.197 0.055 0.186 0.065
0.263 0.010 0.134 0.176
0.062 0.951 0.004 0.997
0.341 0.001 0.318 0.001
0.108 0.285 0.255 0.009
0.079 0.447 0.208 0.034
0.047 0.657 0.189 0.064
0.350 <0.001 0.149 0.131
0.118 0.257 0.047 0.639
0.093 0.364 0.064 0.526
0.040 0.703 0.074 0.473
icate those outcomes which surpassed the multiple comparison test.
ipoprotein cholesterol; SBP, systolic blood pressure. A higher clustered
Mediterranean diet and cardiometabolic status. 2317Mediterranean Diet Score provides the best evidence of
MD adherence. Consequently, we decided to employ this
dietary index to assess MD adherence in this study sample.
Notwithstanding, to accomplish the second objective of
the present study, we analysed the association between
individual components of the Mediterranean dietary
pattern and a clustered cardiometabolic risk previously
employed in pregnant women [2]. We confirmed that
components which are suggested to be protective against
CVD [30], including fruits, vegetables and fish were asso-
ciated with a lower clustered cardiometabolic risk, and
those supposed to be detrimental for CVD [39], including
red meat and subproducts and refined cereals, were
associated with a greater clustered cardiometabolic risk
in this specific population.
Limitation and strengths
The present study has some limitations. First, as this is a
longitudinal study, causality cannot be concluded. Second,
the results should be interpreted cautiously, as we could
be limited to detect small association sizes. Larger studies
should further explore these associations in order to
corroborate our results. Regarding strengths, we assessed
dietary habits and cardiometabolic status in both, the 16th
and 34th g.w., and we employed a widely used Mediter-
ranean Diet Score. In addition, we included a wide range
of cardiometabolic factors within the overall risk score
created, which strengthen the usefulness of our results.
Conclusion
Overall, our results indicate that a higher MD adher-
ence could be associated with better cardiometabolic
markers and a cardioprotective effect throughout gesta-
tion. Regarding MD components, a higher intake of fruits,
vegetables and fish and a lower intake of refined cereals
and red meat and subproducts might be associated with
lower cardiometabolic risk during pregnancy.
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